{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T13:48:23Z","timestamp":1767016103811,"version":"3.48.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Orthop Surg Traumatol"],"DOI":"10.1007\/s00590-025-04502-2","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T18:30:39Z","timestamp":1756405839000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Type 2 statin use increased perioperative blood loss in primary reverse total shoulder arthroplasty"],"prefix":"10.1007","volume":"35","author":[{"given":"Kotaro","family":"Yamakado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Katsutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Nagamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayato","family":"Satake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsukasa","family":"Kumai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"issue":"1","key":"4502_CR1","doi-asserted-by":"publisher","first-page":"CD004816","DOI":"10.1002\/14651858","volume":"31","author":"F Taylor","year":"2013","unstructured":"Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, Ward K, Ebrahim S (2013) Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 31(1):CD004816. https:\/\/doi.org\/10.1002\/14651858","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"4502_CR2","first-page":"404","volume":"29","author":"WC Huang","year":"2013","unstructured":"Huang WC, Lin TW, Chiou KR, Cheng CC, Kuo FY, Chiang CH, Yang JS, Lin KL, Hsiao SH, Yeh TC, Mar GY, Hsiao HC, Lin SL, Chiou CW, Liu CP (2013) The effect of intensified low density lipoprotein cholesterol reduction on recurrent myocardial infarction and cardiovascular mortality. Acta Cardiol Sin. 29(5):404\u2013412","journal-title":"Acta Cardiol Sin."},{"issue":"8","key":"4502_CR3","doi-asserted-by":"publisher","first-page":"533","DOI":"10.7326\/M14-1430","volume":"162","author":"MC Odden","year":"2015","unstructured":"Odden MC, Pletcher MJ, Coxson PG, Thekkethala D, Guzman D, Heller D, Goldman L, Bibbins-Domingo K (2015) Cost-effectiveness and population impact of statins for primary prevention in adults aged 75 years or older in the USA. Ann Intern Med 162(8):533\u2013541. https:\/\/doi.org\/10.7326\/M14-1430","journal-title":"Ann Intern Med"},{"issue":"23","key":"4502_CR4","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.3390\/cells12232719","volume":"12","author":"C Siniscalchi","year":"2023","unstructured":"Siniscalchi C, Basaglia M, Riva M, Meschi M, Meschi T, Castaldo G, Di Micco P (2023) Statins effects on blood clotting: a review. Cells 12(23):2719. https:\/\/doi.org\/10.3390\/cells12232719","journal-title":"Cells"},{"issue":"9411","key":"4502_CR5","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0140-6736(04)15690-0","volume":"363","author":"R Collins","year":"2004","unstructured":"Collins R, Armitage J, Parish S, Sleight P, Peto R (2004) Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet 363(9411):757\u2013767. https:\/\/doi.org\/10.1016\/S0140-6736(04)15690-0","journal-title":"Lancet"},{"issue":"24 Pt 2","key":"4502_CR6","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1212\/01.wnl.0000296277.63350.77","volume":"70","author":"LB Goldstein","year":"2008","unstructured":"Goldstein LB, Amarenco P, Szarek M, Callahan A 3rd, Hennerici M, Sillesen H, Zivin JA, Welch KM (2008) Hemorrhagic stroke in the stroke prevention by aggressive reduction in cholesterol levels study. Neurology 70(24 Pt 2):2364\u20132370. https:\/\/doi.org\/10.1212\/01.wnl.0000296277.63350.77","journal-title":"Neurology"},{"issue":"20","key":"4502_CR7","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1161\/CIRCULATIONAHA.111.055269","volume":"124","author":"DG Hackam","year":"2011","unstructured":"Hackam DG, Woodward M, Newby LK, Bhatt DL, Shao M, Smith EE, Donner A, Mamdani M, Douketis JD, Arima H, Chalmers J, MacMahon S, Tirschwell DL, Psaty BM, Bushnell CD, Aguilar MI, Capampangan DJ, Werring DJ, De Rango P, Viswanathan A, Danchin N, Cheng CL, Yang YH, Verdel BM, Lai MS, Kennedy J, Uchiyama S, Yamaguchi T, Ikeda Y, Mrkobrada M (2011) Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis. Circulation 124(20):2233\u20132242. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.055269","journal-title":"Circulation"},{"key":"4502_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/1477-9560-12-26","volume":"12","author":"PS Wells","year":"2014","unstructured":"Wells PS, Gebel M, Prins MH, Davidson BL, Lensing AW (2014) Influence of statin use on the incidence of recurrent venous thromboembolism and major bleeding in patients receiving rivaroxaban or standard anticoagulant therapy. Thromb J 12:26. https:\/\/doi.org\/10.1186\/1477-9560-12-26","journal-title":"Thromb J"},{"issue":"1","key":"4502_CR9","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.1503\/cmaj.160303","volume":"189","author":"T Antoniou","year":"2016","unstructured":"Antoniou T, Macdonald EM, Yao Z, Hollands S, Gomes T, Tadrous M, Mamdani MM, Juurlink DN (2016) Association between statin use and ischemic stroke or major hemorrhage in patients taking dabigatran for atrial fibrillation. CMAJ 189(1):E4\u2013E10. https:\/\/doi.org\/10.1503\/cmaj.160303","journal-title":"CMAJ"},{"issue":"1","key":"4502_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s40256-018-0301-4","volume":"19","author":"AI Martinez","year":"2019","unstructured":"Martinez AI, Freeman PR, Moga DC (2019) Statin use and gastrointestinal hemorrhage: a large retrospective cohort study. Am J Cardiovasc Drugs 19(1):65\u201374. https:\/\/doi.org\/10.1007\/s40256-018-0301-4","journal-title":"Am J Cardiovasc Drugs"},{"issue":"5","key":"4502_CR11","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/ane.13077","volume":"139","author":"BL Ho","year":"2019","unstructured":"Ho BL, Lin YJ, Lin SF, Chou PS, Chen CF, Lin RT, Hu HH, Chao AC (2019) Statins and the risk of bleeding in patients taking dabigatran. Acta Neurol Scand 139(5):455\u2013461. https:\/\/doi.org\/10.1111\/ane.13077","journal-title":"Acta Neurol Scand"},{"key":"4502_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ejim.2019.07.028","volume":"68","author":"C Siniscalchi","year":"2019","unstructured":"Siniscalchi C, Quintavalla R, Rocci A, Riera-Mestre A, Trujillo-Santos J, Suri\u00f1ach JM, Jara-Palomares L, Bikdeli B, Moustafa F, Monreal M (2019) Statin and all-cause mortality in patients receiving anticoagulant therapy for venous thromboembolism. data from the RIETE registry. Eur J Intern Med 68:30\u201335. https:\/\/doi.org\/10.1016\/j.ejim.2019.07.028","journal-title":"Eur J Intern Med"},{"issue":"7","key":"4502_CR13","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1177\/10600280211049727","volume":"56","author":"AS Bhagavathula","year":"2022","unstructured":"Bhagavathula AS, Vidyasaga K, Gebreyohannes EA, Tesfaye W (2022) Risk of gastrointestinal bleeding on treatment with statin alone or with concomitant administration of warfarin: a systematic review and meta-analysis of 5.3 million participants. Ann Pharmacother 56(7):820\u2013830. https:\/\/doi.org\/10.1177\/10600280211049727","journal-title":"Ann Pharmacother"},{"issue":"3","key":"4502_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ph16030364","volume":"16","author":"H Chung","year":"2023","unstructured":"Chung H, Kim JM, Park JW, Noh J, Kim KA, Park JY (2023) Effects of simvastatin on pharmacokinetics and anticoagulant effects of dabigatran in healthy subjects. Pharmaceuticals (Basel) 16(3):364. https:\/\/doi.org\/10.3390\/ph16030364","journal-title":"Pharmaceuticals (Basel)"},{"key":"4502_CR15","doi-asserted-by":"publisher","DOI":"10.3399\/BJGP.2024.0349","author":"AY Wong","year":"2025","unstructured":"Wong AY, Warren-Gash C, Bhaskaran K, Leyrat C, Banerjee A, Smeeth L, Douglas IJ (2025) Potential interactions between direct oral anticoagulants and atorvastatin\/simvastatin: a cohort and case-crossover study. Br J Gen Pract. https:\/\/doi.org\/10.3399\/BJGP.2024.0349","journal-title":"Br J Gen Pract"},{"key":"4502_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2025.108723","volume":"249","author":"C Cui","year":"2025","unstructured":"Cui C, Yin Q, Li J (2025) Statins reduce the recurrence of spontaneous intracerebral hemorrhage: a systematic review and meta-analysis. Clin Neurol Neurosurg 249:108723. https:\/\/doi.org\/10.1016\/j.clineuro.2025.108723","journal-title":"Clin Neurol Neurosurg"},{"issue":"5","key":"4502_CR17","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s10557-019-06904-x","volume":"33","author":"V Azemawah","year":"2019","unstructured":"Azemawah V, Movahed MR, Centuori P, Penaflor R, Riel PL, Situ S, Shadmehr M, Hashemzadeh M (2019) State of the art comprehensive review of individual statins, their differences, pharmacology, and clinical implications. Cardiovasc Drugs Ther 33(5):625\u2013639. https:\/\/doi.org\/10.1007\/s10557-019-06904-x","journal-title":"Cardiovasc Drugs Ther"},{"issue":"5","key":"4502_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/cvm-2-5-205","volume":"2","author":"CD Furberg","year":"2001","unstructured":"Furberg CD, Pitt B (2001) Withdrawal of cerivastatin from the world market. Curr Control Trials Cardiovasc Med 2(5):205\u2013207. https:\/\/doi.org\/10.1186\/cvm-2-5-205","journal-title":"Curr Control Trials Cardiovasc Med"},{"issue":"1","key":"4502_CR19","doi-asserted-by":"publisher","first-page":"CD012501","DOI":"10.1002\/14651858.CD012501.pub2","volume":"1","author":"SP Adams","year":"2020","unstructured":"Adams SP, Tiellet N, Alaeiilkhchi N, Wright JM (2020) Cerivastatin for lowering lipids. Cochrane Database Syst Rev 1(1):CD012501. https:\/\/doi.org\/10.1002\/14651858.CD012501.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"4502_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1537","volume":"374","author":"T Cai","year":"2021","unstructured":"Cai T, Abel L, Langford O, Monaghan G, Aronson JK, Stevens RJ, Lay-Flurrie S, Koshiaris C, McManus RJ, Hobbs FDR, Sheppard JP (2021) Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses. BMJ 374:n1537. https:\/\/doi.org\/10.1136\/bmj.n1537","journal-title":"BMJ"},{"issue":"8","key":"4502_CR21","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1007\/s00590-024-04084-5","volume":"34","author":"K Yamakado","year":"2024","unstructured":"Yamakado K (2024) Influence of statin use on progression of postoperative fatty infiltration in the arthroscopic rotator cuff repair. Eur J Orthop Surg Traumatol 34(8):3955\u20133960. https:\/\/doi.org\/10.1007\/s00590-024-04084-5","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"4502_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.arthro.2024.11.066","author":"K Yamakado","year":"2024","unstructured":"Yamakado K (2024) Statin use not linked to rotator cuff retear after arthroscopic rotator cuff repair. Arthroscopy. https:\/\/doi.org\/10.1016\/j.arthro.2024.11.066","journal-title":"Arthroscopy"},{"issue":"3","key":"4502_CR23","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1302\/0301-620x.86b3.14024","volume":"86","author":"F Sirveaux","year":"2004","unstructured":"Sirveaux F, Favard L, Oudet D, Huquet D, Walch G, Mol\u00e9 D (2004) Grammont inverted total shoulder arthroplasty in the treatment of glenohumeral osteoarthritis with massive rupture of the cuff. Results of a multicentre study of 80 shoulders. J Bone Joint Surg Br 86(3):388\u2013395. https:\/\/doi.org\/10.1302\/0301-620x.86b3.14024","journal-title":"J Bone Joint Surg Br"},{"issue":"8","key":"4502_CR24","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.2106\/JBJS.E.00851","volume":"88","author":"J Guery","year":"2006","unstructured":"Guery J, Favard L, Sirveaux F, Oudet D, Mole D, Walch G (2006) Reverse total shoulder arthroplasty. survivorship analysis of eighty replacements followed for five to ten years. J Bone Joint Surg Am 88(8):1742\u20131747. https:\/\/doi.org\/10.2106\/JBJS.E.00851","journal-title":"J Bone Joint Surg Am"},{"issue":"9","key":"4502_CR25","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1007\/s11999-011-1833-y","volume":"469","author":"L Favard","year":"2011","unstructured":"Favard L, Levigne C, Nerot C, Gerber C, De Wilde L, Mole D (2011) Reverse prostheses in arthropathies with cuff tear: ARE survivorship and function maintained over time? Clin Orthop Relat Res 469(9):2469\u20132475. https:\/\/doi.org\/10.1007\/s11999-011-1833-y","journal-title":"Clin Orthop Relat Res"},{"issue":"9","key":"4502_CR26","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1302\/0301-620X.93B9.25926","volume":"93","author":"B Melis","year":"2011","unstructured":"Melis B, DeFranco M, L\u00e4dermann A, Mol\u00e9 D, Favard L, N\u00e9rot C, Maynou C, Walch G (2011) An evaluation of the radiological changes around the Grammont reverse geometry shoulder arthroplasty after eight to 12 years. J Bone Joint Surg Br 93(9):1240\u20131246. https:\/\/doi.org\/10.1302\/0301-620X.93B9.25926","journal-title":"J Bone Joint Surg Br"},{"issue":"6","key":"4502_CR27","doi-asserted-by":"publisher","first-page":"454","DOI":"10.2106\/JBJS.16.00223","volume":"99","author":"G Bacle","year":"2017","unstructured":"Bacle G, Nov\u00e9-Josserand L, Garaud P, Walch G (2017) Long-term outcomes of reverse total shoulder arthroplasty: a follow-up of a previous study. J Bone Joint Surg Am 99(6):454\u2013461. https:\/\/doi.org\/10.2106\/JBJS.16.00223","journal-title":"J Bone Joint Surg Am"},{"issue":"4","key":"4502_CR28","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jse.2018.10.005","volume":"28","author":"L Ernstbrunner","year":"2019","unstructured":"Ernstbrunner L, Andronic O, Grubhofer F, Camenzind RS, Wieser K, Gerber C (2019) Long-term results of reverse total shoulder arthroplasty for rotator cuff dysfunction: a systematic review of longitudinal outcomes. J Shoulder Elbow Surg 28(4):774\u2013781. https:\/\/doi.org\/10.1016\/j.jse.2018.10.005","journal-title":"J Shoulder Elbow Surg"},{"issue":"3","key":"4502_CR29","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/00000542-198303000-00016","volume":"58","author":"JB Gross","year":"1983","unstructured":"Gross JB (1983) Estimating allowable blood loss: corrected for dilution. Anesthesiology 58(3):277\u2013280. https:\/\/doi.org\/10.1097\/00000542-198303000-00016","journal-title":"Anesthesiology"},{"issue":"2","key":"4502_CR30","first-page":"224","volume":"51","author":"SB Nadler","year":"1962","unstructured":"Nadler SB, Hidalgo JH (1962) Prediction of blood volume in normal human adults. Surgery 51(2):224\u2013232","journal-title":"Surgery"},{"issue":"2","key":"4502_CR31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jse.2008.08.005","volume":"18","author":"KI Gruson","year":"2009","unstructured":"Gruson KI, Accousti KJ, Parsons BO, Pillai G, Flatow EL (2009) Transfusion after shoulder arthroplasty: an analysis of rates and risk factors. J Shoulder Elbow Surg 18(2):225\u2013230. https:\/\/doi.org\/10.1016\/j.jse.2008.08.005","journal-title":"J Shoulder Elbow Surg"},{"issue":"3","key":"4502_CR32","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00402-017-2851-3","volume":"138","author":"D Malcherczyk","year":"2018","unstructured":"Malcherczyk D, Abdelmoula A, Heyse TJ, Peterlein CD, Greene B, El-Zayat BF (2018) Bleeding in primary shoulder arthroplasty. Arch Orthop Trauma Surg 138(3):317\u2013323. https:\/\/doi.org\/10.1007\/s00402-017-2851-3","journal-title":"Arch Orthop Trauma Surg"},{"issue":"9","key":"4502_CR33","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1016\/j.jse.2019.01.027","volume":"28","author":"MS Kim","year":"2019","unstructured":"Kim MS, Kim JD, Ro KH, Park JJ, Rhee YG (2019) Hematologic profile in reverse total shoulder arthroplasty: perioperative and postoperative blood loss. J Shoulder Elbow Surg 28(9):1737\u20131742. https:\/\/doi.org\/10.1016\/j.jse.2019.01.027","journal-title":"J Shoulder Elbow Surg"},{"key":"4502_CR34","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.jses.2019.08.003","volume":"15","author":"KA Burns","year":"2019","unstructured":"Burns KA, Robbins LM, LeMarr AR, Childress AL, Morton DJ, Wilson ML (2019) Estimated blood loss and anemia predict transfusion after total shoulder arthroplasty: a retrospective cohort study. JSES Open Access 15:311\u2013315. https:\/\/doi.org\/10.1016\/j.jses.2019.08.003","journal-title":"JSES Open Access"},{"key":"4502_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1053\/j.sart.2022.07.013","volume":"33","author":"CE Hays","year":"2023","unstructured":"Hays CE, Pharr ZK, Goedecke PJ, Qi Zhao Q, Brolin TJ, Azar FM, Throckmorton T (2023) Does the transfusion rate following reverse total shoulder arthroplasty warrant aggressive perioperative blood management? An indications-based analysis. Seminars in Arthroplasty: JSES 33:1\u20137. https:\/\/doi.org\/10.1053\/j.sart.2022.07.013","journal-title":"Seminars in Arthroplasty: JSES"},{"issue":"5","key":"4502_CR36","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.jse.2024.08.024","volume":"34","author":"K Yamakado","year":"2025","unstructured":"Yamakado K (2025) Impact of antiplatelet and anticoagulant drugs on postoperative bleeding in reverse total shoulder arthroplasty. J Shoulder Elbow Surg 34(5):1131\u20131138.\u00a0doi: 10.1016\/j.jse.2024.08.024.","journal-title":"J Shoulder Elbow Surg"}],"container-title":["European Journal of Orthopaedic Surgery & Traumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00590-025-04502-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00590-025-04502-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00590-025-04502-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T13:43:36Z","timestamp":1767015816000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00590-025-04502-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4502"],"URL":"https:\/\/doi.org\/10.1007\/s00590-025-04502-2","relation":{},"ISSN":["1432-1068"],"issn-type":[{"type":"electronic","value":"1432-1068"}],"subject":[],"published":{"date-parts":[[2025,8,28]]},"assertion":[{"value":"29 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"363"}}